Dr Monga Opticians Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 28-12-2024
- Paid Up Capital ₹ 0.10 M
as on 28-12-2024
- Company Age 24 Year, 6 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 2.84%
(FY 2020)
- Profit -45.16%
(FY 2020)
- Ebitda -111.61%
(FY 2020)
- Net Worth 9.93%
(FY 2020)
- Total Assets 9.77%
(FY 2020)
About Dr Monga Opticians
The Company is engaged in the Consumer Goods Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shailender Monga, Gurvinder Monga, Paramjit Monga, and One other member serve as directors at the Company.
- CIN/LLPIN
U74899DL2001PTC109178
- Company No.
109178
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jan 2001
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Dr Monga Opticians Private Limited offer?
Dr Monga Opticians Private Limited offers a wide range of products and services, including Eyewear Manufacturers, Toric Lens, Ind Chem, Silver Acetate, Infections Drugs, Trimethoprim, Optical Lenses, Ophthalmic Lenses, Colored Contact Lenses, Single Vision Lens.
Who are the key members and board of directors at Dr Monga Opticians?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shailender Monga  | Director | 12-Jan-2001 | Current |
| Gurvinder Monga | Director | 12-Jan-2001 | Current |
| Paramjit Monga | Director | 12-Jan-2001 | Current |
| Baljit Monga | Director | 12-Jan-2001 | Current |
Financial Performance of Dr Monga Opticians.
Dr Monga Opticians Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 2.84% increase. The company also saw a substantial fall in profitability, with a 45.16% decrease in profit. The company's net worth moved up by a moderate rise of 9.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr Monga Opticians?
In 2019, Dr Monga Opticians had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Speccasa Global Eyewear Private LimitedActive 7 years 2 months
Shailender Monga and Gurvinder Monga are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dr Monga Opticians?
Unlock and access historical data on people associated with Dr Monga Opticians, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr Monga Opticians, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr Monga Opticians's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
